Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Glenmark Pharmaceuticals Limited
Press Release Dec 23 2020
Published Dec 23 2020
5 min read

Press Release Dec 23 2020

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 23, 2020, titled "Glenmark Pharmaceuticals and Menarini enter into Exclusive Licensing Agreement for commercializing Ryaltris Nasal Spray across numerous markets throughout Europe".

View Attachment